Should KRAS mutation still be used as a routine predictor of response to EGFR-TKIs in advanced non-small-cell lung cancer? A revaluation based on meta-analysis-Reference-Cited by-同舟云学术

Should KRAS mutation still be used as a routine predictor of response to EGFR-TKIs in advanced non-small-cell lung cancer? A revaluation based on meta-analysis

Published:2015-01-11 Issue:8 Volume:141 Page:1427-1439
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Ying Min,Zhu Xiaoxia,Chen Kexu,Sha Zhou,Chen Longhua

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-015-1910-9.pdf

Reference54 articles.

1. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101

2. Boldrini L, Alì G, Gisfredi S et al (2009) Epidermal growth factor receptor and K-RAS mutations in 411 lung adenocarcinoma: a population-based prospective study. Oncol Rep 22:683–691

3. Brugger W, Triller N, Blasinska-Morawiec M et al (2011) Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer. J Clin Oncol 29:4113–4120

4. Califano R, Landi L, Cappuzzo F (2012) Prognostic and predictive value of K-RAS mutations in non-small cell lung cancer. Drugs 72:28–36

5. Cappuzzo F, Ligorio C, Janne PA et al (2007) Prospective study of gefitinib in epidermal growth factor receptor fluorescence in situ hybridization-positive/phospho-Akt-positive or never smoker patients with advanced non-small-cell lung cancer: the ONCOBELL trial. J Clin Oncol 25:2248–2255

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation analysis of clinical, pathological, imaging and genetic features of ground-glass nodule featured lung adenocarcinomas between high-risk and non-high-risk individuals;European Journal of Medical Research;2023-11-04

2. Correlation analysis of clinical, pathological, imaging and genetic features of ground-glass nodule featured lung adenocarcinomas between high-risk and non-high-risk individuals;2023-10-16

3. KRAS oncogene may be another target conquered in non‐small cell lung cancer ( NSCLC );Thoracic Cancer;2020-10-06

4. Profiles of immune infiltration in lung adenocarcinoma and their clinical significant: A gene‐expression–based retrospective study;Journal of Cellular Biochemistry;2020-01-31

5. Biomarkers in Non-Small Cell Lung Cancer: Perspectives of Individualized Targeted Therapy;Anti-Cancer Agents in Medicinal Chemistry;2019-02-28